Sandrock Joins Voyager As CEO To Advance New Gene Therapy Technology Into The Clinic

The former Biogen executive will succeed interim CEO Michael Higgins, who will continue as chairman.

orange baton
Voyager appointed Al Sandrock as CEO • Source: Alamy

Former Biogen, Inc. R&D chief Al Sandrock is the new CEO of gene therapy specialist Voyager Therapeutics, Inc bringing extensive experience in neuroscience to the role but less gene therapy expertise. Voyager announced the appointment on 22 March, with Sandrock succeeding interim CEO Michael Higgins, who will remain chairman of the board.

The news comes just weeks after Sandrock joined Voyager's board of directors in February and a new executive committee aimed...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Gene Therapies

More from Advanced Therapies